Literature DB >> 34402933

Predictors of Neurological Outcome Following Infant Cardiac Surgery Without Deep Hypothermic Circulatory Arrest.

Agnieszka Kosiorek1,2, Mary T Donofrio3, David Zurakowski4, Justus G Reitz2, Lauren Tague5, Jonathan Murnick6, Roland Axt-Fliedner2, Catherine Limperopoulos7, Can Yerebakan8, Jessica L Carpenter9.   

Abstract

The aim of this study is to describe the clinical characteristics, perioperative course and neuroimaging abnormalities of infants with congenital heart disease (CHD) undergoing heart surgery without deep hypothermic circulatory arrest (DHCA) and identify variables associated with neurological outcome. Infants with CHD undergoing open-heart surgery without DHCA between 2009 and 2017 were identified from a cardiac surgery database. Full-term infants < 10 weeks of age at the time of surgery who had both a pre- and postoperative brain magnetic resonance imaging exam (MRI) were included. Clinical characteristics and perioperative variables were collected from the electronic medical record. Brain Injury Scores (BIS) were assigned to pre- and postoperative brain MRIs. Variables were examined for association with neurological outcome at 12 months of age or greater. Forty-two infants were enrolled in the study, of whom 69% (n = 29) had a neurological assessment ≥ to 12 months of age. Adverse neurological outcome was associated with longer intensive care unit (ICU) stay (P = 0.003), lengthier mechanical ventilation (P = 0.031), modified Blalock-Taussig (MBT) shunt procedure (P = 0.005) and postoperative seizures (P = 0.005). Total BIS scores did not predict outcome but postoperative infarction and/or intraparenchymal hemorrhage (IPH) was associated with worse outcome by multivariable analysis (P = 0.018). Infants with CHD undergoing open-heart surgery without DHCA are at increased risk of worse neurological outcome when their ICU stay is prolonged, mechanical ventilation is extended, MBT shunt is performed or when postoperative seizures are present. Cerebral infarctions and IPH on postoperative MRI are also associated with worse outcome.
© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Congenital heart disease (CHD); Magnetic resonance imaging (MRI); Neurodevelopmental; Outcome; Stroke

Mesh:

Year:  2021        PMID: 34402933     DOI: 10.1007/s00246-021-02693-z

Source DB:  PubMed          Journal:  Pediatr Cardiol        ISSN: 0172-0643            Impact factor:   1.655


  53 in total

1.  Mortality associated with congenital heart defects in the United States: trends and racial disparities, 1979-1997.

Authors:  R S Boneva; L D Botto; C A Moore; Q Yang; A Correa; J D Erickson
Journal:  Circulation       Date:  2001-05-15       Impact factor: 29.690

Review 2.  Birth prevalence of congenital heart disease worldwide: a systematic review and meta-analysis.

Authors:  Denise van der Linde; Elisabeth E M Konings; Maarten A Slager; Maarten Witsenburg; Willem A Helbing; Johanna J M Takkenberg; Jolien W Roos-Hesselink
Journal:  J Am Coll Cardiol       Date:  2011-11-15       Impact factor: 24.094

3.  Temporal trends in survival among infants with critical congenital heart defects.

Authors:  Matthew E Oster; Kyung A Lee; Margaret A Honein; Tiffany Riehle-Colarusso; Mikyong Shin; Adolfo Correa
Journal:  Pediatrics       Date:  2013-04-22       Impact factor: 7.124

Review 4.  Adult Congenital Heart Disease: Scope of the Problem.

Authors:  Efrat Mazor Dray; Ariane J Marelli
Journal:  Cardiol Clin       Date:  2015-08-14       Impact factor: 2.213

Review 5.  Neurodevelopmental Outcomes of the Child with Congenital Heart Disease.

Authors:  Beatrice Latal
Journal:  Clin Perinatol       Date:  2016-03       Impact factor: 3.430

6.  The challenge of congenital heart disease worldwide: epidemiologic and demographic facts.

Authors:  Pierre-Luc Bernier; Ada Stefanescu; Gordan Samoukovic; Christo I Tchervenkov
Journal:  Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu       Date:  2010

Review 7.  Current Interventional and Surgical Management of Congenital Heart Disease: Specific Focus on Valvular Disease and Cardiac Arrhythmias.

Authors:  Kimberly A Holst; Sameh M Said; Timothy J Nelson; Bryan C Cannon; Joseph A Dearani
Journal:  Circ Res       Date:  2017-03-17       Impact factor: 17.367

8.  Lifetime prevalence of congenital heart disease in the general population from 2000 to 2010.

Authors:  Ariane J Marelli; Raluca Ionescu-Ittu; Andrew S Mackie; Liming Guo; Nandini Dendukuri; Mohammed Kaouache
Journal:  Circulation       Date:  2014-06-18       Impact factor: 29.690

9.  Neurodevelopmental outcomes in children with congenital heart disease: evaluation and management: a scientific statement from the American Heart Association.

Authors:  Bradley S Marino; Paul H Lipkin; Jane W Newburger; Georgina Peacock; Marsha Gerdes; J William Gaynor; Kathleen A Mussatto; Karen Uzark; Caren S Goldberg; Walter H Johnson; Jennifer Li; Sabrina E Smith; David C Bellinger; William T Mahle
Journal:  Circulation       Date:  2012-07-30       Impact factor: 29.690

10.  Global birth prevalence of congenital heart defects 1970-2017: updated systematic review and meta-analysis of 260 studies.

Authors:  Yingjuan Liu; Sen Chen; Liesl Zühlke; Graeme C Black; Mun-Kit Choy; Ningxiu Li; Bernard D Keavney
Journal:  Int J Epidemiol       Date:  2019-04-01       Impact factor: 7.196

View more
  2 in total

1.  Brain MRI Radiomics Analysis of School-Aged Children with Tetralogy of Fallot.

Authors:  Yiwei Pu; Songmei Li; Siyu Ma; Yuanli Hu; Qinghui Hu; Yuting Liu; Mengting Wu; Jia An; Ming Yang; Xuming Mo
Journal:  Comput Math Methods Med       Date:  2021-10-29       Impact factor: 2.238

2.  In infants with congenital heart disease autonomic dysfunction is associated with pre-operative brain injury.

Authors:  Sarah D Schlatterer; Rathinaswamy B Govindan; Jonathan Murnick; Scott D Barnett; Catherine Lopez; Mary T Donofrio; Sarah B Mulkey; Catherine Limperopoulos; Adre J du Plessis
Journal:  Pediatr Res       Date:  2021-12-28       Impact factor: 3.953

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.